CCRN — Cross Country Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- $606.85m
- $589.76m
- $2.02bn
- 91
- 97
- 46
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -55.9 | -12.1 | 132 | 188 | 72.6 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 30.4 | 30.5 | 19.7 | 34.1 | 28.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14.2 | -2.85 | -237 | -106 | 127 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 5.54 | 27.2 | -85.6 | 134 | 248 |
Capital Expenditures | -2.94 | -4.62 | -7.17 | -8.79 | -14 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0 | -26.9 | -35.1 | 0.199 |
Acquisition of Business | |||||
Sale of Business | |||||
Cash from Investing Activities | -2.94 | -4.62 | -34 | -43.9 | -13.8 |
Financing Cash Flow Items | -4.7 | -2.02 | -8.58 | -17.1 | -12.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -17.6 | -22 | 119 | -87.6 | -221 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -15 | 0.568 | -0.564 | 2.57 | 13.5 |